{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:06:22Z","timestamp":1784761582503,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Wuhai City Science and Technology Project","award":["2024WHSKJJN20"],"award-info":[{"award-number":["2024WHSKJJN20"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To evaluate the association between triple therapy (hydroxychloroquine sulfate, aspirin, and enoxaparin sodium) and pregnancy outcomes in patients with undifferentiated connective tissue disease (UCTD)-related recurrent miscarriage (RM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study included 135 pregnant women with recurrent miscarriage treated at a single center between January 2021 and August 2024. Patients were assigned to three groups according to treatment regimen: control group 1 (progesterone\u2009+\u2009enoxaparin sodium), control group 2 (aspirin\u2009+\u2009enoxaparin sodium), and the triple therapy group (hydroxychloroquine\u2009+\u2009aspirin\u2009+\u2009enoxaparin sodium). The primary outcome was live birth (\u2265\u200928 weeks). Multivariable logistic regression analysis was performed to adjust for baseline differences using a parsimonious model including treatment group, maternal age, and gestational age at last pregnancy loss.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In unadjusted analysis, the triple therapy group had a significantly higher live birth rate (95.6%) than the control group 1 (80.0%) and control group 2 (77.8%) (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.028). The higher live birth rate was mainly driven by increased fetal survival, despite a numerically higher preterm birth rate. After adjustment for baseline differences, the association between triple therapy and live birth was attenuated and did not reach statistical significance, although the direction of effect remained consistent with the unadjusted analysis. No significant difference was observed between control group 2 and control group 1 in the adjusted analysis. Gestational age at last pregnancy loss was significantly associated with live birth, whereas maternal age was not. No increase in adverse reactions or differences in neonatal outcomes was observed among the groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Triple therapy with hydroxychloroquine, aspirin, and enoxaparin sodium was associated with improved live birth outcomes in patients with UCTD-related recurrent miscarriage. However, this association was attenuated and did not remain statistically significant after adjustment for baseline differences. Given the retrospective design and limited sample size, further prospective studies are required to confirm these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-026-09337-1","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:44:45Z","timestamp":1779842685000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of hydroxychloroquine sulfate combined with aspirin and enoxaparin sodium therapy on perinatal outcomes in patients with undifferentiated connective tissue disease-related recurrent miscarriage: a retrospective clinical study"],"prefix":"10.1186","volume":"26","author":[{"given":"Liu-Cheng","family":"Pei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Juan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Di","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Chao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"9337_CR1","doi-asserted-by":"publisher","unstructured":"Xiang Z, et al. Fertility intention and its affecting factors in China: A national cross-sectional survey. Heliyon. Feb. 2023;9(2). https:\/\/doi.org\/10.1016\/j.heliyon.2023.e13445.","DOI":"10.1016\/j.heliyon.2023.e13445"},{"key":"9337_CR2","doi-asserted-by":"publisher","first-page":"e078635","DOI":"10.1136\/BMJ-2023-078635","volume":"386","author":"Y Wang","year":"2024","unstructured":"Wang Y, Kong F, Fu Y, Qiao J. How can China tackle its declining fertility rate? BMJ. 2024;386:e078635. https:\/\/doi.org\/10.1136\/BMJ-2023-078635.","journal-title":"BMJ"},{"key":"9337_CR3","doi-asserted-by":"publisher","unstructured":"Nielsen JR, et al. Evaluating risk factors in recurrent pregnancy loss: A prospective cohort study and its impact on live birth outcomes. J Reprod Immunol. Sep. 2024;165:104297. https:\/\/doi.org\/10.1016\/J.JRI.2024.104297.","DOI":"10.1016\/J.JRI.2024.104297"},{"key":"9337_CR4","doi-asserted-by":"publisher","first-page":"l869","DOI":"10.1136\/BMJ.L869","volume":"364","author":"MC Magnus","year":"2019","unstructured":"Magnus MC, Wilcox AJ, Morken NH, Weinberg CR, H\u00e5berg SE. Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. BMJ. 2019;364:l869. https:\/\/doi.org\/10.1136\/BMJ.L869.","journal-title":"BMJ"},{"key":"9337_CR5","doi-asserted-by":"publisher","unstructured":"Hansda J, J. R.-T. J. of O. and, of G. and undefined 2012, Study of thrombophilia in recurrent pregnancy loss, SpringerJ Hansda, J RoychowdhuryThe Journal of Obstetrics and Gynecology of India, 2012\u2022Springer, vol. 62, no. 5, pp. 536\u2013540, Oct. 2012. https:\/\/doi.org\/10.1007\/S13224-012-0197-X","DOI":"10.1007\/S13224-012-0197-X"},{"key":"9337_CR6","doi-asserted-by":"publisher","unstructured":"Cohn DM, Goddijn M, Middeldorp S, Korevaar JC, Dawood F, Farquharson RG. Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy. J Thromb Haemost. Oct. 2010;8(10):2208\u201313. https:\/\/doi.org\/10.1111\/J.1538-7836.2010.04015.X.","DOI":"10.1111\/J.1538-7836.2010.04015.X"},{"key":"9337_CR7","unstructured":"Di FAF et al. Prima Antiphospholipid Syndrome during pregnancy: the state of the art, J. Prenat. Med., vol. 5, no. 2, p. 41, Apr. 2011, Accessed: May 08, 2026. [Online]. Available: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3279165\/"},{"key":"9337_CR8","doi-asserted-by":"publisher","unstructured":"Hussein A et al. Jan., \u2018Unraveling the Clot-Miscarriage Nexus: Mechanisms, Management, and Future Directions in Thrombosis-Related Recurrent Pregnancy Loss,\u2019 Clinical and Applied Thrombosis\/Hemostasis, vol. 31, p. 10760296251339420, 2025, https:\/\/doi.org\/10.1177\/10760296251339421","DOI":"10.1177\/10760296251339421"},{"key":"9337_CR9","doi-asserted-by":"publisher","unstructured":"Murthy RASAA, K SL. Maternal thrombophilia and intrauterine growth restriction: A review of current evidence and clinical implications. Endocr Metabolic Sci. Dec. 2025;19:100274. https:\/\/doi.org\/10.1016\/J.ENDMTS.2025.100274.","DOI":"10.1016\/J.ENDMTS.2025.100274"},{"key":"9337_CR10","doi-asserted-by":"publisher","unstructured":"Bundgaard E, Pedersen MK, Bor P, Bor MV. Revisiting the link between factor XII and recurrent pregnancy loss: a scoping review. Am J Reprod Immunol. 2025;94(2):e70127. https:\/\/doi.org\/10.1111\/aji.70127.","DOI":"10.1111\/aji.70127"},{"key":"9337_CR11","doi-asserted-by":"publisher","unstructured":"Jacobson B, et al. Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic Review and Meta-Analysis. Adv Ther. Jan. 2019;37(1):27. https:\/\/doi.org\/10.1007\/S12325-019-01124-Z.","DOI":"10.1007\/S12325-019-01124-Z"},{"key":"9337_CR12","doi-asserted-by":"publisher","unstructured":"Porter TF, Gyamfi-Bannerman C, Manuck T. ACOG COMMITTEE OPINION Number 743 Low-Dose Aspirin Use during Pregnancy. Obstet Gynecol. Jul. 2018;132(1):E44\u201352. https:\/\/doi.org\/10.1097\/AOG.0000000000002708.","DOI":"10.1097\/AOG.0000000000002708"},{"key":"9337_CR13","doi-asserted-by":"publisher","unstructured":"Kaandorp SP et al. Apr., Aspirin plus heparin or aspirin alone in women with recurrent miscarriage, N. Engl. J. Med., vol. 362, no. 17, pp. 1586\u20131596, 2010, https:\/\/doi.org\/10.1056\/NEJMOA1000641","DOI":"10.1056\/NEJMOA1000641"},{"key":"9337_CR14","doi-asserted-by":"publisher","unstructured":"Motta F, et al. Role of placental inflammatory mediators and growth factors in patients with rheumatic diseases with a focus on systemic sclerosis. Rheumatology (Oxford). Jul. 2020;60(7):3307. https:\/\/doi.org\/10.1093\/RHEUMATOLOGY\/KEAA782.","DOI":"10.1093\/RHEUMATOLOGY\/KEAA782"},{"key":"9337_CR15","doi-asserted-by":"publisher","unstructured":"Wu XX, Guller S, Rand JH. Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression, Am. J. Obstet. Gynecol., vol. 205, no. 6, p. 576.e7-576.e14, 2011. https:\/\/doi.org\/10.1016\/j.ajog.2011.06.064","DOI":"10.1016\/j.ajog.2011.06.064"},{"key":"9337_CR16","doi-asserted-by":"publisher","unstructured":"Yuan T, Xu J, Chen D, Yang C, Peng B. The additional use of hydroxychloroquine can improve the live birth rate in pregnant women with persistent positive antiphospholipid antibodies: A systematic review and meta-analysis. J Gynecol Obstet Hum Reprod. Oct. 2021;50(8):102121. https:\/\/doi.org\/10.1016\/J.JOGOH.2021.102121.","DOI":"10.1016\/J.JOGOH.2021.102121"},{"key":"9337_CR17","doi-asserted-by":"publisher","unstructured":"Mosca M, Tani C, Vagnani S, Carli L, Bombardieri S. The diagnosis and classification of undifferentiated connective tissue diseases. J Autoimmun. Feb. 2014;48\u20139. https:\/\/doi.org\/10.1016\/J.JAUT.2014.01.019.","DOI":"10.1016\/J.JAUT.2014.01.019"},{"key":"9337_CR18","unstructured":"Evaluation and treatment of recurrent pregnancy loss: a committee opinion. (2012) | American Society for Reproductive Medicine | ASRM. Accessed: Apr. 27, 2026. [Online]. Available: https:\/\/www.asrm.org\/practice-guidance\/practice-committee-documents\/evaluation-and-treatment-of-recurrent-pregnancy-loss-a-committee-opinion-2012\/?utm_source=chatgpt.com"},{"key":"9337_CR19","doi-asserted-by":"publisher","unstructured":"Firatligil FB, Yildirir BF, Yalcin-Ozuysal O. A new insight into the pathway behind spontaneous recurrent pregnancy loss: decreased CYR61 gene expression, Rev. Assoc. Med. Bras. (1992), vol. 70, no. 6, 2024. https:\/\/doi.org\/10.1590\/1806-9282.20231673","DOI":"10.1590\/1806-9282.20231673"},{"key":"9337_CR20","doi-asserted-by":"publisher","unstructured":"Fierro JJ, Vel\u00e1squez-Berr\u00edo M, Ospina A, Henning S, de Leeuw K, Cadavid \u00c1P. J, The effects of hydroxychloroquine and its promising use in refractory obstetric antiphospholipid syndrome, Rheumatology International 2023 44:2, vol. 44, no. 2, pp. 223\u2013234, Sep. 2023, https:\/\/doi.org\/10.1007\/S00296-023-05457-5","DOI":"10.1007\/S00296-023-05457-5"},{"key":"9337_CR21","doi-asserted-by":"publisher","unstructured":"Demers S, Roberge S, Bujold E. Re: Impact of aspirin on trophoblastic invasion in women with abnormal uterine artery Doppler at 11\u201314 weeks. Ultrasound Obstet Gynecol. 2017;49(5):664\u20135. https:\/\/doi.org\/10.1002\/uog.17450.","DOI":"10.1002\/uog.17450"},{"key":"9337_CR22","doi-asserted-by":"publisher","unstructured":"Han CS, et al. Aspirin and heparin effect on basal and antiphospholipid antibody modulation of trophoblast function. Obstet Gynecol. Nov. 2011;118(5):1021\u20138. https:\/\/doi.org\/10.1097\/AOG.0B013E31823234AD.","DOI":"10.1097\/AOG.0B013E31823234AD"},{"key":"9337_CR23","doi-asserted-by":"crossref","unstructured":"S. Yang et al., A three-arm, multicenter, open-label randomized controlled trial of hydroxychloroquine and low-dose prednisone to treat recurrent pregnancy loss in women with undifferentiated connective tissue diseases: Protocol for the Immunosuppressant regimens for LI\u2026 Trials, vol. 21, no. 1, p. 771-, Sep. 2020, doi: 10.1186\/S13063-020-04716-1\/FIGURES\/2.","DOI":"10.1186\/s13063-020-04716-1"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-026-09337-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09337-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09337-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T22:55:48Z","timestamp":1784760948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-026-09337-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9337"],"URL":"https:\/\/doi.org\/10.1186\/s12884-026-09337-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8387593\/v1","asserted-by":"object"}]},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. The research protocol was approved by the Ethics Committee of Wuhai Maternity and Child Health Care Hospital (Ethic Approval Number: ZG202410), and all of the participants provided signed informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors consent to publish.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"801"}}